Dapagliflozin vs Ipilimumab

## Dapagliflozin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Ipilimumab**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Ipilimumab — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Ipilimumab — N/A.

**Type**: Dapagliflozin — Small molecule; Ipilimumab — Antibody.